Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Trieste

152 clinical trials in Trieste, Italy across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Trieste at a glance
152
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

152 trials in Trieste

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:GSK3862995B
  • Sponsor:GSK PLC
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Ntc S.r.l.
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Generate Biomedicines Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:ZIGAKIBART
  • Sponsor:Novartis Pharma AG
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Arsenic Trioxide
  • Sponsor:Associazione Italiana Ematologia Oncologia Pediatrica
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Lonapegsomatropin
  • Sponsor:Ascendis Pharma Endocrinology Division A/S
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Kura Oncology Inc.
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years
  • Substances:Blinatumomab
  • Sponsor:Universita Degli Studi Di Milano Bicocca

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Trieste

What the registry says about research in the country

01 Hematologic Conditions

Groundbreaking research focusing on blood disorders and malignancies, including innovative treatments for leukemia and lymphoma. Clinical trials are evaluating new therapeutic combinations and targeted approaches.

  • Multiple Myeloma
  • Hairy Cell Leukemia
  • Immune Thrombocytopenia

Studies are exploring both chemotherapy-free alternatives and novel drug combinations to improve patient outcomes.

02 Pulmonary Diseases

Advanced research into respiratory conditions, with a particular focus on progressive lung disorders. Studies are evaluating new therapeutic approaches for managing chronic conditions.

  • Idiopathic Pulmonary Fibrosis
  • Malignant Pleural Mesothelioma

Trials aim to assess treatment efficacy through measurement of vital capacity and disease progression markers.

03 Oncology Research

Comprehensive studies of various cancer types, incorporating innovative therapeutic approaches and targeted treatments. Focus on both rare and common malignancies.

  • Non-Small Cell Lung Cancer
  • Basal Cell Carcinoma
  • Osteosarcoma

Research emphasizes personalized medicine approaches and combination therapies.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.